Solid Biosciences Inc’s filing revealed that its Chief Regulatory Officer Hanrahan Jessie unloaded Company’s shares for reported $25822.0 on Dec 03 ’24. In the deal valued at $5.60 per share,4,610 shares were sold. As a result of this transaction, Hanrahan Jessie now holds 14,235 shares worth roughly $59644.65000000001.
Then, Howton David T bought 5,072 shares, generating $28,396 in total proceeds.
Before that, Cumbo Alexander sold 11,114 shares. Solid Biosciences Inc shares valued at $62,236 were divested by the President and CEO at a price of $5.60 per share. As a result of the transaction, Cumbo Alexander now holds 38,484 shares, worth roughly $0.16 million.
Wedbush initiated its Solid Biosciences Inc [SLDB] rating to an Outperform in a research note published on December 13, 2024; the price target was $16. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in early December with a ‘”a Mkt outperform”‘ rating. JP Morgan also remained covering SLDB and has increased its forecast on July 15, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Leerink Partners revised its rating on June 24, 2024. It rated SLDB as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of SLDB
On Tuesday, Solid Biosciences Inc [NASDAQ:SLDB] saw its stock jump 2.20% to $4.19. Over the last five days, the stock has lost -6.28%. Solid Biosciences Inc shares have fallen nearly -31.92% since the year began. Nevertheless, the stocks have fallen -22.30% over the past one year. While a 52-week high of $15.05 was reached on 03/28/24, a 52-week low of $3.90 was recorded on 12/20/24. SMA at 50 days reached $5.39, while 200 days put it at $7.95.
Levels Of Support And Resistance For SLDB Stock
The 24-hour chart illustrates a support level at 4.08, which if violated will result in even more drops to 3.99. On the upside, there is a resistance level at 4.26. A further resistance level may holdings at 4.35. The Relative Strength Index (RSI) on the 14-day chart is 34.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.33%. Stochastics %K at 15.43% indicates the stock is a buying.
How much short interest is there in Solid Biosciences Inc?
A steep rise in short interest was recorded in Solid Biosciences Inc stocks on 2024-11-29, growing by 67521.0 shares to a total of 1.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 1.48 million shares. There was a rise of 4.36%, which implies that there is a positive sentiment for the stock.
